HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sichuan Xi Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

9/2006Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
9/2004SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
4/2003Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth.
4/2002Differential function of STAT5 isoforms in head and neck cancer growth control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sichuan Xi Research Topics

Disease

29Neoplasms (Cancer)
04/2024 - 04/2002
14Squamous Cell Carcinoma of Head and Neck
12/2008 - 04/2002
9Carcinogenesis
04/2024 - 09/2004
6Lung Neoplasms (Lung Cancer)
07/2021 - 10/2010
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2017
4Head and Neck Neoplasms (Head and Neck Cancer)
09/2006 - 04/2002
3Adenocarcinoma
01/2023 - 11/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2022 - 09/2003
3Carcinoma (Carcinomatosis)
10/2022 - 08/2012
2Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2024 - 11/2022
2Fibrosis (Cirrhosis)
02/2024 - 11/2022
2Mesothelioma
01/2021 - 01/2012
2Neoplasm Metastasis (Metastasis)
01/2017 - 01/2017
2Esophageal Neoplasms (Esophageal Cancer)
01/2014 - 08/2012
2Hematologic Neoplasms (Hematological Malignancy)
01/2014 - 05/2008
1Silicosis
02/2024
1Adenocarcinoma of Lung
01/2018
1Genomic Instability
01/2017
1Pneumonia (Pneumonitis)
04/2013
1Malignant Mesothelioma
01/2012
1Testicular Neoplasms (Testicular Cancer)
06/2011
1Acute Erythroblastic Leukemia (Erythroleukemia)
05/2008
1Leukemia
05/2008
1Glioblastoma (Glioblastoma Multiforme)
09/2006
1Anemia
06/2005
1Fatigue
06/2005

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
04/2024 - 08/2002
7ErbB Receptors (EGF Receptor)IBA
12/2008 - 04/2002
6SmokeIBA
01/2023 - 10/2010
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 10/2004
5DNA (Deoxyribonucleic Acid)IBA
03/2013 - 08/2002
4MicroRNAs (MicroRNA)IBA
01/2023 - 10/2010
3Phosphotransferases (Kinase)IBA
10/2022 - 08/2002
3Transcription Factors (Transcription Factor)IBA
02/2005 - 04/2003
26-methyladenineIBA
04/2024 - 06/2018
2Liposomes (Liposome)IBA
02/2024 - 11/2022
2LigandsIBA
02/2024 - 09/2004
2Small Interfering RNA (siRNA)IBA
02/2024 - 11/2022
2UbiquitinIBA
11/2022 - 01/2021
2Bile Acids and Salts (Bile Acids)IBA
01/2020 - 11/2017
2Histone Deacetylase InhibitorsIBA
01/2018 - 06/2011
2Gastrin-Releasing PeptideIBA
05/2006 - 09/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2005 - 08/2002
2Cyclin D1IBA
02/2005 - 08/2002
2src-Family KinasesIBA
09/2004 - 08/2003
2Transforming Growth Factor alpha (TGF-alpha)IBA
09/2004 - 09/2003
2Protein Isoforms (Isoforms)IBA
10/2003 - 04/2002
1N-methyladenosineIBA
04/2024
1Clodronic Acid (Clodronate)IBA
02/2024
1Silicon Dioxide (Silica)FDA LinkGeneric
02/2024
1Neutralizing AntibodiesIBA
02/2024
1BX 471IBA
02/2024
1RNA (Ribonucleic Acid)IBA
02/2024
1Beclin-1IBA
11/2022
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
10/2022
1Type I Tumor Necrosis Factor ReceptorsIBA
10/2022
1EpiregulinIBA
07/2021
1aaptamineIBA
12/2020
1ThioredoxinsIBA
01/2018
1Sodium SeleniteIBA
01/2018
1entinostat (MS 275)IBA
01/2018
1Uncoupling Protein 2IBA
11/2017
1norcantharidinIBA
01/2017
15-hydroxymethylcytosineIBA
01/2017
1Crystallins (Crystallin)IBA
07/2014
1CateninsIBA
01/2014
1Cytoskeletal ProteinsIBA
01/2014
1telomerase RNA (bTR)IBA
01/2014
1Telomerase (Telomerase Reverse Transcriptase)IBA
01/2014
1Nucleosomes (Nucleosome)IBA
03/2013
1PlicamycinFDA Link
08/2012
1XenobioticsIBA
08/2012
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2012
1Histones (Histone)IBA
06/2011
1ChromatinIBA
06/2011
1AntigensIBA
06/2011
1Lysine (L-Lysine)FDA Link
06/2011
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2011
13-deazaneplanocinIBA
06/2011
1Tyrosine Kinase InhibitorsIBA
12/2008
1STAT5 Transcription FactorIBA
12/2008
1proto-oncogene protein Spi-1IBA
05/2008
1epidermal growth factor receptor VIIIIBA
09/2006
1Cetuximab (Erbitux)FDA Link
09/2006
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2006
1STAT1 Transcription FactorIBA
02/2006
1hydrogen sulfite (bisulfite)IBA
02/2006
1ErythropoietinFDA Link
06/2005
1Janus KinasesIBA
06/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2005
1Staphylococcal Protein A (Protein A)IBA
10/2004
1Epidermal Growth Factor (EGF)IBA
09/2004
1Matrix Metalloproteinase InhibitorsIBA
09/2004
1AmphiregulinIBA
09/2004
1Bombesin Receptors (Bombesin Receptor)IBA
09/2004

Therapy/Procedure

9Therapeutics
01/2021 - 02/2005
2Drug Therapy (Chemotherapy)
12/2008 - 06/2005
1Intravenous Administration
11/2022
1Immunotherapy
06/2011
1Radiotherapy
06/2005